Robert Morris
Robert Morris is the editor of Penny Stock All-Stars, an investment advisory focused on discovering small-cap and micro-cap stocks that are destined to become the market’s next Blue Chips.
The Wall Street veteran and small-cap stock specialist is also a regular contributor to Penny Stock Research. Every week, Robert shares his thoughts with our readers on a variety of penny stock-related topics.
In addition to Penny Stock Research, Robert also writes frequently for two other free financial e-letters, ETF Trading Research and the Dynamic Wealth Report. He’s also the editor of two highly successful and popular investment advisories, Biotech SuperTrader and China Stock Insider.
Robert Morris's Latest Posts
US Government Bonds: Get Out Of Long-Term US Government Bonds Now!
Do you own US government bonds in your portfolio? If you do, the time has come to head for the exits. The smart money is dumping Treasuries like there’s no tomorrow. Earlier this week the Bond King himself, Bill Gross, made a startling move. Gross manages PIMCO’s Total Return Fund, the largest bond fund in […]
Stock Market Fears: Overcome Your Fear Right Now!
Fear is a powerful emotion. We’ve all felt it many times before. The flood of adrenaline shooting through your body and sharpening your senses. Your heart pounding so hard it feels like it will burst out of your chest. It’s frightening yet thrilling at the same time. Fear is also one of our most basic […]
Financial Stocks: The End Of An American Icon?
It’s a sad time for Wall Street and America. Yesterday news broke the New York Stock Exchange is about to be acquired by Deutsche Börse AG. This is a big blow to American pride. And it’s yet another sign of the USA’s fading dominance of the financial world. If the deal goes through, the 219-year […]
China Stocks: Big Bargains In Chinese Stocks
China bashing is the latest fad in financial journalism. Every day the news carries article after article criticizing the Chinese economy, Chinese government, Chinese companies, and most of all, Chinese stocks. This merciless campaign of negativity has been going on for months now. It seems like China’s economic challenges are bringing the critics out of […]
Protect Your Profits Now!
Back in mid-January, Intel (INTC) shocked the investment world with a bold statement. The company said they’re going to spend a whopping $9 billion in capital expenditures this year. In case you don’t know, that’s a huge number! First of all, it’s a jaw-dropping 73% higher than last year’s capital spending of $5.2 billion. What’s […]
Drug Stocks Crumbling… What To Do Now!
Big Pharma stocks are core holdings for many investors. You might even have one or two in your own portfolio. If you do, I’m sorry to say I have bad news for you. Drug stocks are facing major challenges in 2011. For years, drug stocks like Pfizer (PFE), Johnson & Johnson (JNJ), Merck (MRK), and […]
The Next Big Time In Drug Delivery Technology
A number of biotech stocks are gearing up for big moves in 2011. Several have potential blockbuster drugs in mid- to late- stage clinical trials. And good results could mean potential revenues of a billion dollars or more per year. But the biotech industry is about more than just finding cures for disease. In fact, […]
Dow Stocks: Don’t Chase This Dow Stock
With the Dow Jones Industrial Average closing in on 12,000, you’re probably looking at more than a few Dow stocks to add to your portfolio. And why not? Given the strong outlook for corporate earnings growth this year, many Dow stocks are bound to provide nice gains in 2011. I too have been taking a […]
Capital Gains Stocks: Should You Take Capital Gains Right Now?
The holiday season is always a bitter-sweet time of year for me. The sweet part is getting to celebrate the holidays with my two wonderful daughters here in Arizona. The bitter part is I’m usually unable to share the holidays with my parents and extended family. You see my parents, my 92-year old grandmother, and […]
Muni Bonds: Muni Bond Plunge Begins…
Is the municipal bond market on the verge of collapse? If recent trading activity is any guide, it certainly looks like it. Over the past couple weeks, muni bonds have suffered their worst decline in almost two years. Take a look at a chart of the iShares S&P National AMT-Free Municipal Bond Fund (MUB). MUB […]
